PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28249136
OWN - NLM
STAT- MEDLINE
DA  - 20170301
DCOM- 20170303
LR  - 20170303
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 376
IP  - 9
DP  - 2017 Mar 02
TI  - Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
PG  - 891
LID - 10.1056/NEJMc1615712 [doi]
FAU - Williams, Thomas C
AU  - Williams TC
AD  - Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom
      [email protected]
FAU - Stewart, Emma
AU  - Stewart E
AD  - NHS Lothian, Edinburgh, United Kingdom.
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Hemoglobin A, Glycosylated)
SB  - AIM
SB  - IM
CON - N Engl J Med. 2016 Nov 10;375(19):1834-1844. PMID: 27633186
CIN - N Engl J Med. 2017 Mar 2;376(9):890-892. PMID: 28249135
MH  - Cardiovascular Diseases
MH  - *Diabetes Mellitus, Type 2
MH  - *Hemoglobin A, Glycosylated
MH  - Humans
EDAT- 2017/03/02 06:00
MHDA- 2017/03/04 06:00
CRDT- 2017/03/02 06:00
AID - 10.1056/NEJMc1615712#SA3 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Mar 2;376(9):891. doi: 10.1056/NEJMc1615712.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>